BC
Bruce & Co Portfolio holdings
AUM
$308M
This Quarter Return
+12.93%
1 Year Return
+16.62%
3 Year Return
+23.4%
5 Year Return
+75.93%
10 Year Return
+183.38%
AUM
$287M
AUM Growth
+$287M
(-2.3%)
Cap. Flow
-$27.8M
Cap. Flow
% of AUM
-9.69%
Top 10 Holdings %
Top 10 Hldgs %
72.59%
Holding
38
New
–
Increased
3
Reduced
15
Closed
–
Top Buys
| 1 |
Darling Ingredients
DAR
|
$3.49M |
| 2 |
Vicor
VICR
|
$449K |
| 3 |
Personalis
PSNL
|
$315K |
Top Sells
| 1 |
Pfizer
PFE
|
$7.23M |
| 2 |
Allstate
ALL
|
$4.2M |
| 3 |
AbbVie
ABBV
|
$3.87M |
| 4 |
Xcel Energy
XEL
|
$3.14M |
| 5 |
AT&T
T
|
$2.52M |
Sector Composition
| 1 | Healthcare | 30.78% |
| 2 | Utilities | 28.46% |
| 3 | Industrials | 19.55% |
| 4 | Communication Services | 6.73% |
| 5 | Financials | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Caribou Biosciences
CRBU
$174M
| $1.15M | 0.4% |
200,000
| – | – |
|
27
908 Devices
MASS
$226M
| $766K | 0.27% |
68,286
| – | – |
|
28
MannKind Corp
MNKD
$1.41B
| $710K | 0.25% |
195,073
| – | – |
|
29
Viatris
VTRS
$12.3B
| $631K | 0.22% |
58,252
| – | – |
|
|
30
Personalis
PSNL
$434M
| $630K | 0.22% |
300,000
+150,000
| +100% | +$315K |
|
|
IGMS
31
DELISTED
IGM Biosciences
IGMS
| $540K | 0.19% |
65,000
-55,000
| -46% | -$457K |
|
32
Fate Therapeutics
FATE
$120M
| $535K | 0.19% |
143,000
-57,000
| -29% | -$213K |
|
33
Organon & Co
OGN
$2.45B
| $450K | 0.16% |
31,190
| – | – |
|
34
RLI Corp
RLI
$6.22B
| $266K | 0.09% |
2,000
| – | – |
|
35
Warner Bros
WBD
$28.8B
| $121K | 0.04% |
10,642
-1,209
| -10% | -$13.8K |
|